Trial Profile
Comparison of the effect of insulin detemir and NPH insulin on dawn phenomenon in patients with Type 1 diabetes An open-labelled, randomised, cross-over, multi-center trial comparing the effect of insulin detemir versus NPH insulin as basal insulins on dawn phenomenon and the glycaemic control in patients with Type 1 diabetes treated on a basal-bolus regimen
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2011
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 23 May 2011 New trial record